NeuroSense Therapeutics (NRSN) EBIT (2021 - 2024)
NeuroSense Therapeutics' (NRSN) quarterly EBIT came in at -$1.8 million in Q4 2024, up 42.16% year-over-year from -$1.2 million in Q1 2024, and up 15.95% quarter-over-quarter from -$2.1 million in Q3 2024.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) EBIT (2021 - 2024) Analysis & Trends
NeuroSense Therapeutics has disclosed EBIT across 4 years of filings, most recently posting -$1.8 million for Q4 2024.
- In Q4 2024, EBIT rose 42.16% year-over-year to -$1.8 million; the TTM figure through Dec 2024 stood at -$9.9 million (up 17.82% YoY), while the FY2025 annual figure was -$11.1 million, down 11.95% from the prior year.
- EBIT came in at -$1.8 million for Q4 2024 at NeuroSense Therapeutics, up from -$2.1 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $957000.0 in Q4 2021 to a low of -$3.6 million in Q2 2022.
- Average EBIT over 4 years is -$2.4 million, with a median of -$3.0 million recorded in 2024.
- Year-over-year, EBIT sank 703.67% in 2023 and soared 42.16% in 2024.
- Over 4 years, EBIT stood at $957000.0 in 2021, then sank by 139.81% to -$381000.0 in 2022, then plunged by 703.67% to -$3.1 million in 2023, then soared by 42.16% to -$1.8 million in 2024.
- Per Business Quant data, the three most recent EBIT figures were -$1.8 million in Q4 2024, -$2.1 million in Q3 2024, and -$3.0 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -815.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 493.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -365.99 Mn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1.77 Mn |
| Sep 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -3.03 Mn |
| Mar 31, 2024 | -2.99 Mn |
| Dec 31, 2023 | -3.06 Mn |
| Sep 30, 2023 | -2.63 Mn |
| Jun 30, 2023 | -3.37 Mn |
| Mar 31, 2023 | -2.99 Mn |
| Dec 31, 2022 | -381,000.00 |
| Sep 30, 2022 | -3.32 Mn |
| Jun 30, 2022 | -3.59 Mn |
| Mar 31, 2022 | -3.26 Mn |
| Dec 31, 2021 | 957,000.00 |
API Access
NeuroSense Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();